AEZS
Price
$2.09
Change
-$0.05 (-2.34%)
Updated
May 1, 6:59 PM EST
5 days until earnings call
PRTA
Price
$21.42
Change
+$1.08 (+5.31%)
Updated
May 1, 6:59 PM EST
5 days until earnings call
Ad is loading...

AEZS vs PRTA ᐉ Comparison: Which is Better to Invest?

Header iconAEZS vs PRTA Comparison
Open Charts AEZS vs PRTABanner chart's image
Aeterna Zentaris
Price$2.09
Change-$0.05 (-2.34%)
Volume$44.59K
CapitalizationN/A
Prothena
Price$21.42
Change+$1.08 (+5.31%)
Volume$437.4K
CapitalizationN/A
View a ticker or compare two or three
AEZS vs PRTA Comparison Chart

Loading...

AEZSDaily Signal changed days agoGain/Loss if shorted
 
Show more...
PRTADaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
AEZS vs. PRTA commentary
May 02, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AEZS is a StrongSell and PRTA is a StrongBuy.

COMPARISON
Comparison
May 02, 2024
Stock price -- (AEZS: $2.07 vs. PRTA: $21.42)
Brand notoriety: AEZS and PRTA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AEZS: 405% vs. PRTA: 91%
Market capitalization -- AEZS: $10.02M vs. PRTA: $1.15B
AEZS [@Biotechnology] is valued at $10.02M. PRTA’s [@Biotechnology] market capitalization is $1.15B. The market cap for tickers in the [@Biotechnology] industry ranges from $578.54B to $0. The average market capitalization across the [@Biotechnology] industry is $2.62B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AEZS’s FA Score shows that 0 FA rating(s) are green whilePRTA’s FA Score has 0 green FA rating(s).

  • AEZS’s FA Score: 0 green, 5 red.
  • PRTA’s FA Score: 0 green, 5 red.
According to our system of comparison, AEZS is a better buy in the long-term than PRTA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AEZS’s TA Score shows that 5 TA indicator(s) are bullish while PRTA’s TA Score has 6 bullish TA indicator(s).

  • AEZS’s TA Score: 5 bullish, 3 bearish.
  • PRTA’s TA Score: 6 bullish, 2 bearish.
According to our system of comparison, PRTA is a better buy in the short-term than AEZS.

Price Growth

AEZS (@Biotechnology) experienced а +5.08% price change this week, while PRTA (@Biotechnology) price change was +4.18% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.39%. For the same industry, the average monthly price growth was -4.43%, and the average quarterly price growth was +1237.50%.

Reported Earning Dates

AEZS is expected to report earnings on Aug 08, 2024.

PRTA is expected to report earnings on Aug 07, 2024.

Industries' Descriptions

@Biotechnology (+3.39% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for AEZS with price predictions.
OPEN
A.I.dvisor published
a Summary for PRTA with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
PRTA($1.15B) has a higher market cap than AEZS($10M). AEZS YTD gains are higher at: 11.290 vs. PRTA (-41.057).
AEZSPRTAAEZS / PRTA
Capitalization10M1.15B1%
EBITDAN/AN/A-
Gain YTD11.290-41.057-27%
P/E RatioN/AN/A-
RevenueN/AN/A-
Total CashN/AN/A-
Total DebtN/AN/A-
FUNDAMENTALS RATINGS
AEZS vs PRTA: Fundamental Ratings
AEZS
PRTA
OUTLOOK RATING
1..100
6714
VALUATION
overvalued / fair valued / undervalued
1..100
53
Fair valued
65
Fair valued
PROFIT vs RISK RATING
1..100
10076
SMR RATING
1..100
9794
PRICE GROWTH RATING
1..100
5791
P/E GROWTH RATING
1..100
9492
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

AEZS's Valuation (53) in the Biotechnology industry is in the same range as PRTA (65). This means that AEZS’s stock grew similarly to PRTA’s over the last 12 months.

PRTA's Profit vs Risk Rating (76) in the Biotechnology industry is in the same range as AEZS (100). This means that PRTA’s stock grew similarly to AEZS’s over the last 12 months.

PRTA's SMR Rating (94) in the Biotechnology industry is in the same range as AEZS (97). This means that PRTA’s stock grew similarly to AEZS’s over the last 12 months.

AEZS's Price Growth Rating (57) in the Biotechnology industry is somewhat better than the same rating for PRTA (91). This means that AEZS’s stock grew somewhat faster than PRTA’s over the last 12 months.

PRTA's P/E Growth Rating (92) in the Biotechnology industry is in the same range as AEZS (94). This means that PRTA’s stock grew similarly to AEZS’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AEZSPRTA
RSI
ODDS (%)
N/A
Bullish Trend 1 day ago
81%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
74%
Bullish Trend 1 day ago
83%
Momentum
ODDS (%)
Bullish Trend 1 day ago
77%
Bullish Trend 1 day ago
71%
MACD
ODDS (%)
Bullish Trend 1 day ago
77%
Bullish Trend 1 day ago
87%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
75%
Bullish Trend 1 day ago
81%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 1 day ago
85%
Advances
ODDS (%)
Bullish Trend 9 days ago
74%
Bullish Trend 3 days ago
77%
Declines
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 14 days ago
83%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
74%
Aroon
ODDS (%)
N/A
Bearish Trend 1 day ago
80%
View a ticker or compare two or three
Ad is loading...
AEZSDaily Signal changed days agoGain/Loss if shorted
 
Show more...
PRTADaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FFBFX21.230.36
+1.72%
Emerald Finance & Bking Innovt Fd Inv
LSSNX27.010.08
+0.30%
Loomis Sayles Small Cap Growth N
MVGCX16.09-0.02
-0.12%
MFS Low Volatility Global Equity C
IEDRX11.55-0.02
-0.17%
Voya Large Cap Value R
JVLIX23.61-0.16
-0.67%
JHancock Disciplined Value I

PRTA and

Correlation & Price change

A.I.dvisor indicates that over the last year, PRTA has been loosely correlated with PEPG. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if PRTA jumps, then PEPG could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PRTA
1D Price
Change %
PRTA100%
+5.31%
PEPG - PRTA
53%
Loosely correlated
+12.62%
MDXG - PRTA
43%
Loosely correlated
+18.34%
BEAM - PRTA
42%
Loosely correlated
+2.45%
DNLI - PRTA
41%
Loosely correlated
+4.60%
NTLA - PRTA
41%
Loosely correlated
+5.14%
More